<SEC-DOCUMENT>0001193125-17-157221.txt : 20170504
<SEC-HEADER>0001193125-17-157221.hdr.sgml : 20170504
<ACCEPTANCE-DATETIME>20170504065003
ACCESSION NUMBER:		0001193125-17-157221
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170504
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170504
DATE AS OF CHANGE:		20170504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDNAX, INC.
		CENTRAL INDEX KEY:			0000893949
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				263667538
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12111
		FILM NUMBER:		17811740

	BUSINESS ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323
		BUSINESS PHONE:		9543840175

	MAIL ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PEDIATRIX MEDICAL GROUP INC
		DATE OF NAME CHANGE:	19950801
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d392789d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (date of earliest event reported): May&nbsp;4, 2017 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
Name of Registrant as Specified in Its Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Florida</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>001-12111</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>26-3667538</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of Incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1301 Concord Terrace </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sunrise, Florida 33323 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) (zip code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code (954)&nbsp;384-0175 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;2.02</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Results of Operations and Financial Condition. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&nbsp;4, 2017, MEDNAX, Inc., a Florida corporation
(the &#147;Company&#148;), issued a press release announcing the results of its operations for the three months ended March&nbsp;31, 2017 (the &#147;First Quarter Release&#148;).&nbsp;A copy of the First Quarter Release is attached hereto as Exhibit
99.1 and is hereby incorporated in this Current Report by reference.&nbsp;The information contained in this Item&nbsp;2.02, including Exhibit 99.1, shall not be deemed &#147;filed&#148; with the Securities and Exchange Commission nor incorporated by
reference in any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.</P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(d)</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Exhibits. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">99.1&#151;Press Release of MEDNAX, Inc. dated May&nbsp;4, 2017. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MEDNAX, INC.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: May 4, 2017</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vivian Lopez-Blanco</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vivian Lopez-Blanco</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Financial
Officer</P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.10pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release of MEDNAX, Inc. dated May 4, 2017.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d392789dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g392789snap0001.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR MORE INFORMATION: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charles Lynch </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Strategy and Investor Relations
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">954-384-0175, x 5692 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>charles_lynch@mednax.com</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>FOR IMMEDIATE RELEASE </U></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX Reports
First Quarter GAAP EPS of $0.59; </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Adjusted EPS of $0.75 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FORT LAUDERDALE, Fla</B>., <B>May&nbsp;4, 2017</B> - MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology,
anesthesiology, maternal-fetal medicine, other pediatric services, radiology, and management services, today reported earnings of $0.59 per diluted share for the three months ended March&nbsp;31, 2017. On a non-GAAP basis, MEDNAX reported Adjusted
EPS of $0.75. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the 2017 first quarter, MEDNAX reported the following results as compared to the first quarter of 2016: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Net revenue of $836 million, compared to $753 million; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Net income of $55 million, compared to $68 million; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">EBITDA of $132 million, compared to $144 million. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Our operating results for the first
quarter of 2017 reflected challenges related to changes in payor mix, birth volumes and compensation expenses for non-physician clinicians,&#148; said Roger J. Medel, M.D., Chief Executive Officer of MEDNAX. &#147;As a leading health solutions
provider, we believe we are well-positioned to manage through these challenges, while continuing to execute on our strategic development and growth as an organization. Most important, we remain committed to being the provider of choice to our
partners, based on our ongoing investments in great patient care, clinical research, education, and quality.&#148; </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Operating Results </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX&#146;s net revenue for the three months ended March&nbsp;31, 2017 increased by 11.0 percent, to $835.6 million, from $752.6 million for
the prior-year period, driven by contributions from acquisitions completed since January 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX&#146;s revenue growth attributable
to recent acquisitions was 11.9 percent, while overall same-unit revenue decreased by 0.9 percent when compared to the prior year period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Same-unit revenue from net reimbursement-related factors declined by 0.6 percent for the 2017 first quarter as compared to the prior-year
period. The net decrease in revenue was primarily due to an increase in the percentage of services reimbursed under government programs, partially offset by modest improvements in managed care contracting and the flow through of revenue from price
increases. On a same-unit basis, the percentage of services reimbursed under government programs increased by 90 basis points for the first quarter compared with the prior-year period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Within the Company&#146;s primary specialties, on a same-unit basis, payor mix for anesthesiology services shifted by 190 basis points to
government payors compared to the prior year, while payor mix for neonatology services was relatively unchanged. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Same-unit revenue
attributable to patient volume declined by 0.3 percent for the 2017 first quarter as compared to the prior-year period. The net decrease in revenue was primarily related to declines in neonatology volumes, partially offset by growth in
anesthesiology volumes. For the 2017 first quarter, same-unit neonatal intensive care unit (NICU) patient days decreased by 2.1 percent compared to the prior-year period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Same-unit revenue growth attributable to patient volume reflects one fewer day in the 2017 first quarter, compared to the prior-year period.
This difference impacted the comparison of same-unit patient volume negatively by 50 basis points and same-unit NICU patient days negatively by 110 basis points. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the 2017 first quarter, practice salaries and benefits expense was $572.4 million, compared to $491.8 million in the prior-year period.
Practice salaries and benefits expense as a percentage of net revenue was 68.5 percent for the first quarter of 2017, compared to 65.4 percent in the prior-year period. This increase in expense as a percentage of revenue was primarily attributable
to growth in compensation expense at existing units, including compensation for non-physician clinicians that increased at a faster pace than in previous periods, as compared to a decline in same-unit revenues. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the 2017 first quarter, general and administrative expenses were $103.8 million, as compared to $90.0 million for the prior-year period.
General and administrative expenses as a percentage of net revenue was 12.4 percent for the first quarter of 2017, compared to 12.0 percent in the prior-year period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Earnings before interest, taxes, depreciation and amortization expense (EBITDA), a non-GAAP measure, for the 2017 first quarter was $131.7
million, compared to $143.9 million for the prior-year period. EBITDA as a percentage of net revenue was 15.8 percent for the first quarter of 2017, compared to 19.1 percent in the prior-year period, with this decline primarily reflecting higher
practice salaries and benefits expense as a percentage of revenue. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense was $25.6 million in the first quarter of 2017 compared to
$19.6 million in the first quarter of 2016, an increase of $6.0 million that primarily related to the amortization of intangible assets from recent acquisitions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest expense was $17.8 million in the first quarter of 2017 compared to $14.5 million in the first quarter of 2016, due primarily to an
increase in the average amount of total borrowings between the two periods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX generated net income of $54.7 million for the 2017
first quarter, or $0.59 per diluted share based on a weighted average 93.1&nbsp;million shares outstanding. This compares with net income of $67.9 million, or $0.73 per diluted share, for the 2016 first quarter, based on a weighted average
93.1&nbsp;million shares outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the first quarter of 2017, MEDNAX reported Adjusted EPS, a non-GAAP measure, of $0.75, compared
to $0.87 for the first quarter of 2016. Adjusted EPS is defined as diluted net income attributable to MEDNAX, Inc. per common and common equivalent share excluding non-cash amortization expense and stock-based compensation expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX had cash and cash equivalents of $41.8 million at March&nbsp;31, 2017, and net accounts receivable were $487.7 million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the first quarter of 2017, MEDNAX used $21.8 million to fund operations, which compares to $33.0 million used to fund operations in the
2016 first quarter. MEDNAX typically uses cash during the first quarter of each year as it pays incentive compensation, principally to its physicians, and employee benefit plan matching contributions that were accrued during the prior year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX used approximately $111.4 million during the 2017 first quarter to fund acquisitions and to make contingent purchase price payments for
previously completed acquisitions. During the first quarter, five physician groups were acquired, including the acquisition of Radiology Alliance, which represents the Company&#146;s first acquisition of an on-site radiology practice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also during the first quarter of 2017, MEDNAX used $68.1 million to fund repurchases of its common stock as part of a repurchase program that
was approved by its Board of Directors in July 2013. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At March&nbsp;31, 2017, MEDNAX had total net debt outstanding of $1.9 billion,
consisting primarily of its senior notes, borrowings under its revolving credit facility and term loan. At March 2017, the amount of additional borrowing capacity available under the Company&#146;s revolving credit facility was approximately $715
million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2017 Second Quarter Outlook </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
the 2017 second quarter, MEDNAX expects earnings per share will be in a range of $0.68 to $0.72 per diluted share and Adjusted EPS will be in a range of $0.85 to $0.89. The Adjusted EPS range excludes approximately $0.11 per diluted share of
estimated amortization expense and $0.06 per diluted share of estimated stock-based compensation expense. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, for the 2017 second quarter, MEDNAX expects that EBITDA will decline by eight
percent to 12 percent, compared to the prior-year period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This outlook assumes that total same-unit revenue growth for the three months
ended June&nbsp;30, 2017 will be in a range of flat to negative two percent, compared to the prior-year period. This outlook also assumes an effective tax rate for the second quarter of 2017 of approximately 39 percent. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Non-GAAP Measures </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A reconciliation of EBITDA
and Adjusted EPS to the most directly comparable GAAP measures for the three months ended March&nbsp;31, 2017 and 2016, respectively, is provided in the financial tables of this press release. Additionally, historical reconciliations of EBITDA and
Adjusted EPS to the most directly comparable GAAP measures as well as the reconciliation of forward-looking EBITDA to the most directly comparable GAAP measure are available on the Company&#146;s website at www.mednax.com/investors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Earnings Conference Call </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MEDNAX, Inc., will
host an investor conference call to discuss the quarterly results at 10 a.m., ET today. The conference call Webcast may be accessed from the Company&#146;s Website, <U>www.mednax.com</U>. A telephone replay of the conference call will be available
from 12:00 p.m. ET today through midnight ET May&nbsp;25, 2017 by dialing 800.475.6701, access Code 422870. The replay will also be available at <U>www.mednax.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ABOUT MEDNAX </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MEDNAX, Inc. is a national health solutions
partner comprised of the nation&#146;s leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based
tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX
provides services through a network of more than 3,725 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two
complementary businesses, consisting of a management services company and a consulting services company. Additional information is available at www.mednax.com. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certain statements and information in
this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than </I></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often
characterized by terminology such as &#147;believe&#148;, &#147;hope&#148;, &#147;may&#148;, &#147;anticipate&#148;, &#147;should&#148;, &#147;intend&#148;, &#147;plan&#148;, &#147;will&#148;, &#147;expect&#148;, &#147;estimate&#148;,
&#147;project&#148;, &#147;positioned&#148;, &#147;strategy&#148; and similar expressions, and are based on assumptions and assessments made by MEDNAX&#146;s management in light of their experience and their perception of historical trends, current
conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and
business decisions to differ materially from forward-looking statements are described in MEDNAX&#146;s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled &#147;Risk Factors&#148;, as well
MEDNAX&#146;s current reports on Form 8-K, filed with the Securities and Exchange Commission. </I></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Income </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except per share data) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">835,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">752,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Practice salaries and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">491,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Practice supplies and other operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,584</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">729,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">628,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment and other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,752</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,463</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity in earnings of unconsolidated affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">794</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total non-operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,379</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,051</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax provision</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,411</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,771</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to noncontrolling interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to MEDNAX, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">54,691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">67,899</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to MEDNAX, Inc. per common and common equivalent share (diluted)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average diluted shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,091</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Reconciliation of Net Income Attributable to MEDNAX, Inc. to EBITDA </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to MEDNAX, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">54,691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">67,899</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense, net<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,379</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,051</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax provision</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,411</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,584</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">131,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">143,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Interest expense, net is composed of interest expense, investment and other income and equity in earnings of unconsolidated affiliate. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Reconciliation of Diluted Net Income per Share Attributable to MEDNAX, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>to Adjusted Diluted Net Income per Share Attributable to MEDNAX, Inc. (&#147;Adjusted EPS&#148;) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except per share data) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average dilutive shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center">93,143</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center">93,091</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income and diluted net income per share attributable to MEDNAX, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">54,691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">67,899</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization (net of tax of $6,843 and $5,118)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,704</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation (net of tax of $2,939 and $3,476)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted net income and diluted EPS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">69,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">81,341</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Balance Sheet Highlights </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>As of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,&nbsp;2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,&nbsp;2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">41,839</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">55,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">487,685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">495,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,868</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">660,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">668,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill, other assets, property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,202,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,083,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,424,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,339,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities and shareholders&#146; equity:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">256,321</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">407,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,902,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,705,682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">503,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">465,013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,662,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,578,633</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total shareholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,762,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,760,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities and shareholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,424,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,339,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g392789snap0001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g392789snap0001.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M]Y0CY.52_P"%)GB/B#!)M>SK.W51A^M1/[TB/_A['^SI_P!"7\:O_"<\#?\
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M[W[G[D5\@?4A0!^?/_!0O]I3_A2?PJ;P9X8U#[-\1_B9;7>EZ6]O(JW6@^&
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M^0#^R,P_Z!G]\/\ Y(/^'?/[7/\ T2>7_P *SP5_\T5']O9?_P _?_):G_R
M?V1F'_0,_OA_\D?*'BKPOKG@CQ+KGA#Q-8G3/$/AK4[O1M9T\S07!L]2L)6@
MNK8SVLLD,QCE1EWQ2.AQE6(YKU:-6%:G"K3=X22:]'JOPUZ:'!4ISHSE2J+E
MG!N+6CLUHU=76GDS K0@[CP+\,_B'\3KR^T[X=^"_$7C6_TNUCO=1L_#FG3:
ME<65G++Y$5S<QPC,4+3?(&/!;BL:V(H891=>K&BI72<FDKKIKU-J5"M7;5&E
M*HX[J*;:731'I$O[*/[34*&1_@+\4]JC)V>$M1E8 #)^2*-F/ ["L/[2R_\
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M=WIHON&HJ*2BN5+9+0Z*H&?B%_P5Y_Y#?P._[!?CK_TK\,U]9PQ_S%_]N?\
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M4UT2>Z2^:6G2#;>A[F/?UK+L'C'[U2%Z5276ZT3?K9M^<NVA^9U?0GA!0 A
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MH)N=#27_ %[?7_MV5M%W;Z-GOY!B?9UYX:3M&LKQ73GBOUC^2/Z *^+/K@H
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M'?\ )4OBY_V(&C?^I%7S/$W\#"_]?)?^DGT7#O\ &Q'^"/\ Z4?O/7QI]6%
M'B_[1?@JP^(7P*^*_A'4(EDCU/P/K\EJ6&?(U33+"75='ND/\,D&JV5G,".0
M8JZ\!5>'QF&JQNN6I&]M-&^62^:;1SXNDJV&KTFM)0=EYI77W-(_D64Y ."N
M0#@\$9&<$=B*_35LC\ZV^0M 'Z;?!-AXD_X)Q_M0Z!>9EC\)>,]&\3::""QM
M93-X/O)#$"<+O72[I3C'^O<]Z^=QC]GGF7S@N5RA*#TLG=3WMJ[<Z>VY[V%2
MJ9+C8-:4IJ2]?=>GG96M_F?F37T1X)U$O@OQ+#X,L_B"=+G;PA>^)+[PC%K4
M8\RUB\1:?IUCJTNF717/V:=].OX9X?,VB58YMA)A<+DJU/VSH<UJD8*=O[K;
MBFOFK:=>VE]?8S5)5N7]VY.-^S23L_D].GS3.7K4R-'1]7U3P]JVF:]H6H7>
MDZUHM_:ZII.J6,K07NG:C8S)<6EY:S+S'-%,BL#R.,$$$@S.$*D)4YQ4H233
MBU=-/1IHJ$Y4I1G!N,X-.+6Z:V9^]]M^U'I7[2O[#7QON;Z2UL?B3X5^&^K:
M?XZT2+;%YD[6A2U\2Z;;C'_$HU(12.%3(MYUGMVX2-I?BGET\!F^#BDW1G5@
MZ<NEDTW&_>/GNK,^NCCXXW*\5=J->G2DIQ^3M)+M+\'==F_Y_P"OMSX\* /J
MGXO_ !E&O_ /]G'X*Z3=[M.\!Z!K_B3Q/'$YV2>*==\4>(CIEK.H."]AX?F$
M@XX.NR#J@(\O!X1TL9C,5./+*HXP@W_(H0O;UDG?T1Z.)Q*EA,'A8/2G&4IV
M?VG)I)K^[%)_,^5J]0\X^F_V/?A"?C5^T%X!\)75LUQH%AJ"^*_%8*L81X=\
M-/%?W5M.P&%COKI;+3N>^I#T->?FF)^J8&O53Y9\O)#OS25E;SC\7I%G=EN&
M^M8NE2:O"+YI_P"&.K7STC\S]5_^"JOP?_X2/X9^%?B]I=F'U+X=:F-$UZ2*
M,F0^$_$TT4,$LA7_ )967B!+!5!^Z-7G/K7S?#F*]EB*F%E+EC67-%=.>"=U
MY7C=_P#;J/H,_P /SX>&(2UH/E?^&32[])66S^(_ VOM#Y$Z/P=XJU?P+XL\
M->,_#]PUIK?A37-,U_2IU.-E[I5W%=PJ_K"YB,<B]&CD=3PQK*O2C6HU:,E>
M-2+BUY-6^3[/H[/H:4JDJ-2G4@[2IR4EZIW7Y']>WPU\>:-\3_ '@_XA:!(L
MFD^+M T[6[55;>;=KNW5KFQE; _TBTNQ/:RC'$ELX[5^95Z,L-6JT)Z2I2<7
M\MGUW5F?HE"K&M1IU8?#.*:ZV[J_D[KY';UB:F9K.C:7XBTC4] URQM]4T;6
M;"[TO5--NT$EK?:??0/;7=I/&?O12P2.A (.&X(/-5"4J<HS@^64&G%KHT[I
M_)DRC&<90G%2A)6:>S6S31_*[^UC^SOJO[-_Q8U3PFRW-SX0U?S=<\!:U,"P
MU#P]/.P6QGF"@/JNERG['<C +;(;C 2[CS^BY7CHXW#1FK1J0M&<5]F22UL^
MDMX^6E[IGP688.6"Q#IZNG+6$GU7^<7H_OZGS)7HG"% 'Z'_ /!/;]E[_A=O
MQ&_X3WQ;IYF^&7PVO;6ZNH+B-3;>)_%J!;O2= VN")K&TQ%?WRA2"GV2W;Y;
MTE?"SS,/JE#V%)_OZZ:ZWA#K+Y_#'7>[UY6CV<GP#Q-95JD?W%!IZ[2FM5'7
M=+>7E9/<_I!KX0^T"@ H * "@#\0O^"O/_(;^!W_ &"_'7_I7X9KZSAC_F+_
M .W/_;CYGB/_ )@_^XO_ +C/QLKZP^8/H/\ 9._Y.9^!/_94?!__ *=[:O/S
M3_<,3_U[G_Z1([<O_P!^PO\ U]A_Z4C]//\ @IY^S%_:%A'^T9X+T_-_I4-I
MI?Q.LK6/YKK24"VVD^+V15^:6P_<V%XV<FV>TE("V<K'P.'LPY)?4:KLI7=)
MOH]6X?.[DO.Z['N9Y@;I8RE'6.E5>727;39_)]S\0*^O/E@H _2K_@G'^S$?
MBQ\0O^%K^+M.$WP]^&NHV\NGV]U#OM?$OCF 17>GV)20;+C3])1X+^Y!#JTS
MV,+*R22A? SW,/JM#ZM2=JU=.[3^"&S?K*SBMNKO='MY+@5B*SKU(WI4+672
M4[Z+LU&UVN]D4O\ @J3_ ,G.0_\ 9-O"?_I=X@J^'O\ D7+_ *^3_06??[\O
M^O4/SD?G%7N'BA0!:6QOF4,EE=LI&59;:8J1V((3!%0ZL%IS6MY/_(=FNEA?
M[/O_ /GQO/\ P%G_ /C=+VM/^;\'_D%F']GW_P#SXWG_ ("S_P#QNCVM/^;\
M'_D%F?7_ .P3:7<'[6OP?:6UNHD&H^(?GDMYD08\'^(!R[(%7D@<D=:\W-YQ
MEEF+Y7>T8_\ I<3T<HB_[0PUEI%RO_X!(\R_:J_Y.5^.W_95/&O_ *?+RM\L
M_P!QPW_7N'_I$3#'?[WB/\<OS/ J[SD/UI_X)'?\E2^+G_8@:-_ZD5?,\3?P
M,+_U\E_Z2?1<._QL1_@C_P"E'[SU\:?5A0!Y?\;?$MEX-^#WQ/\ $^H2I!:Z
M+X#\4WA:0[0\RZ->1VD Y&9)KMX(4 Y+2J!R:Z,)!U,3AZ:O[U2"TWMS*[^2
MNS#$S5/#5Y[<E.;^Z+ML?Q^KN"J&.6"C<1T+ <D<#O7ZA^'D?G.WR'4 ?IM\
M"T&@?\$Z?VJM<N\QP^)/%FC>'+ ]#-.&\)6C!,XR%.K.3C/$3>E?.8SWL\R^
M$&FX1<FFU9?$NFJ^%+O?MN>[A;T\EQTMN::C'[X+;YZ^2/S)KZ,\(_<C_@GA
M\,?"7QB_9'^*_P ._&M@M_H/B'XEZM;R%=JW>G7:>%/",EAJVF3D$VNIV5TL
M<\,HSAH]K!HW=&^/SS$5,)FF&K4GRSITH^C7/.Z:[/;\59I,^KR>A3Q&7UJ-
M57A*;3[K16:[-/5'Y-?'GX)>+?V?OB1K/PZ\6Q,\EDWVS0M:CB,=CXF\/7#N
M-.URP.2-LBHT<T.XM;W$,\#\QY;Z7!8RGC</"M3=KZ2CUA+K%^G1Z75G97/G
ML9A9X*O*C/51UC*VDHO9K\GV::/'*ZSE.@\/^*?$'A9M8.@ZG<Z<OB#0-3\+
M:W% Y$.J:!K$:1ZAIE[$?EFMY#%#(,C*2012(5=%(B=*%3EYXIN$E*+MK&4?
MA:\U=V-*=2=+FY)<JE%QDNCBU9IK^K,Y^K,PH * "@#]XO\ @E5\++3PS\/O
M%OQ?U@VT&J>.]2_X1[P_Y\L<<T7A?P[,?MMQ&&?(COM?:=&&!D:'"V,$$_&<
M15Y5,13PT$^6@KR23MS/;_P&+T_Q/KHOK<@P_LZ-3$25I5'RQ[\D=_\ P*7S
MT1^E_P 1?#'AGXD^ _%_@#7;JR?2O%WA[5-!N\SP,8%U"UD@BNXU,G^OMIVB
MN(SVD@0]J\&A.KAJU*M"+4J,E):/H[V?D]GY'MUJ<:U*I1EI&I%Q?E=6OZK=
M>:/Y#O%GAG5/!?BCQ%X0UJ(0:OX8UO5-!U%%(*"\TJ]FLIVB8$AX7>$NC X9
M'4CK7Z;1J1JTJ=6#]V<8R7HTGTZ]S\[J4W2J3I2T=.3B_D[:>78Y^M#,_=?_
M ()2?&4:OX0\8?!#5KK=?^$;MO%WA2.5V9Y/#FM3K#K=G#N.!'8ZZT5QM7_H
M/GLN!\=Q'A/9U*6+@O=J>Y/:W,KN.W>-U_VZNK9]9D&)YJ53"R>M%\T/\+>J
M^4M?^WO(_7FOF#Z$R==US2/#&BZKXBU_4+;2=#T+3[O5=6U*\?R[6PT^P@>Y
MN[J=\'$<<,;L0 2<8 )(!J$)5)QITXN4Y-1BENV]$B92C3C*4GRQBKM[:(_E
M9_:K_:'UC]H_XKZKXPF-S:>%--WZ+X#T*8E1I7AVVE;R[F>+<0NJZE*#>W1Y
M*M-' "8[6/'Z-EF!C@,-&EO4E[U27>79>45HN^_4^#S#&2QN(=354X>[3CVC
M?=J[]Y[OY+HCYKKT#@"@#[O_ &"OVGY/@#\3X_#_ (FOVC^%WQ!N+33/$8F9
MC;>'-8W>3I'BV-<_N8H6?[+?%0=UI-YI#-91"O&SG+UC,/[2G'_:*"O'O**O
M>'ZKL_*YZV4X_P"I5^2H_P!Q5M&6ND'?2=O+5/R=^B/Z7T=)$22-E>-U5T=&
M#(Z, RLC*2&4J001P0:^ M;3:W0^W7EMT'4 % !0 4 ?B%_P5Y_Y#?P._P"P
M7XZ_]*_#-?6<,?\ ,7_VY_[<?,\1_P#,'_W%_P#<9^-E?6'S!]!_LG?\G,_
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MGUU/K\DQWMJ?U6I+][17N-_:@M+>;CI\K=FS]2:^=/>"@ H * /Q"_X*\_\
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MY#_V3;PG_P"EWB"OO.'O^1<O^OD_T/C,^_WY?]>H?G(_.*O</%"@#]'O!?\
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MO\R*F2?T%?\ !)S_ )('XW_[*OJG_J*>$:^(XD_WZE_UYC_Z74/L,@_W2?\
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MEY12DD[VDM)+RU3^5NY^>8W#_5,55H[*,O=_PO6/5]&CQ.NPY0HLKWMKW *
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M ,!B'_#H;P=_T6[Q7_X26B__ "RH_P!9ZG_0)'_P8_\ Y$/]7:/_ $$S_P#
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M"5:&+4M.C7^TXYG99/-DX 50HY8L6MIM8>QY+XXUOQQ\0?B])\'_  =XKO/
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M=/XN^*7P[\1>*E^(%AX!O="32?&OV6SMKFX&L64UU<:/J3:<@M[B^LY(S&S
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
#'__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
